Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-methyl-n-(endo-9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1h-indazole-3-carboxamide
2. 1h-indazole-3-carboxamide, 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl
3. 1h-indazole-3-carboxamide, 1-methyl-n-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, Endo-
4. Brl 43694
5. Brl 43694a
6. Brl-43694
7. Brl-43694a
8. Brl43694
9. Brl43694a
10. Granisetron
11. Granisetron Hydrochloride
12. Granisetron Monohydrochloride
13. Hydrochloride, Granisetron
14. Kytril
15. Monohydrochloride, Granisetron
1. Granisetron
2. 109889-09-0
3. Exo-granisetron (granisetron Impurity F)
4. 1364914-39-5
5. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide
6. Granisetronum [inn-latin]
7. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1h-indazole-3-carboxamide
8. Brl 43694
9. Granisetron-d3
10. Granisetron Base
11. [3h]-granisetron
12. Ly-278584
13. [3h]granisetron
14. Apf-530
15. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1h-indazole-3-carboxamide
16. 1-methyl-n-{9-methyl-9-azabicyclo[3.3.1]nonan-3-yl}-1h-indazole-3-carboxamide
17. [3h]-brl-43694
18. Schembl445223
19. Chembl289469
20. Chembl519643
21. Gtpl2292
22. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide
23. Dtxsid50861188
24. Chebi:184693
25. Bcp10022
26. Ex-a1291
27. Hy-b0071
28. Bbl036319
29. Bdbm50000483
30. Pdsp1_001266
31. Pdsp2_001250
32. Stl483411
33. Akos015895362
34. Ab07494
35. Cs-1509
36. Sdccgsbi-0633801.p001
37. Ncgc00186041-01
38. Ncgc00186041-09
39. Ls-14665
40. Ft-0626805
41. Ab01274752-01
42. Ab01274752_02
43. Ab01274752_03
44. Aa-504/10505045
45. L000281
46. 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]nonan-7-yl)indazole-3-carboxamide
47. 1-methyl-1h-indazole-3-carboxylic Acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide
48. 1-methyl-1h-indazole-3-carboxylic Acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide
49. 1-methyl-n-((1s,5r)-9-methyl-9-aza-bicyclo[3.3.1]nonan-3-yl)-1h-indazole-3-carboxamide
50. N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1-methyl-1h-indazole-3-carboxamide
51. (brl 43694)1-methyl-1h-indazole-3-carboxylic Acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide
52. (granisetron)1-methyl-1h-indazole-3-carboxylic Acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide
53. 1-methyl-1h-indazole-3-carboxylic Acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide(brl 43694)
54. 1-methyl-1h-indazole-3-carboxylic Acid (9-methyl-9-aza-bicyclo[3.3.1]non-3-yl)-amide(granisetron)
55. 2-(9-methyl-3,9-diaza-bicyclo[3.3.1]non-3-yl)-1-(1-methyl-1h-indol-3-yl)-ethanone(granisetron)
Molecular Weight | 312.4 g/mol |
---|---|
Molecular Formula | C18H24N4O |
XLogP3 | 2.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 312.19501140 g/mol |
Monoisotopic Mass | 312.19501140 g/mol |
Topological Polar Surface Area | 50.2 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 442 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Prevention of nausea and vomiting in patients receiving moderately or highly emetogenic chemotherapy, with or without cisplatin, for up to five consecutive days.
Sancuso may be used in patients receiving their first chemotherapy regimen or in patients who have previously received chemotherapy.
Serotonin 5-HT3 Receptor Antagonists
Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS. (See all compounds classified as Serotonin 5-HT3 Receptor Antagonists.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
A04AA02
A - Alimentary tract and metabolism
A04 - Antiemetics and antinauseants
A04A - Antiemetics and antinauseants
A04AA - Serotonin (5ht3) antagonists
A04AA02 - Granisetron
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21790
Submission : 2008-06-24
Status : Active
Type : II
NDC Package Code : 64567-0010
Start Marketing Date : 2009-08-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22311
Submission : 2008-12-15
Status : Active
Type : II
NDC Package Code : 58175-0537
Start Marketing Date : 2006-04-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23128
Submission : 2009-09-25
Status : Active
Type : II
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm :
NDC Package Code : 55111-841
Start Marketing Date : 2009-09-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Sangjin Corporation
Registration Date : 2013-03-05
Registration Number : 20130305-177-I-125-01
Manufacturer Name : Dr. Reddy's Laboratories Limited
Manufacturer Address : APIIC Industrial Estate, Pydibheemavaram Ranasthalam Mandal, Srikakulam District, Andhra Pradesh, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22089
Submission : 2008-09-29
Status : Active
Type : II
NDC Package Code : 14778-0202
Start Marketing Date : 2011-10-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-06-29
Pay. Date : 2015-03-20
DMF Number : 25980
Submission : 2012-04-16
Status : Active
Type : II
NDC Package Code : 54871-1091
Start Marketing Date : 2012-07-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18820
Submission : 2005-09-28
Status : Active
Type : II
Date of Issue : 2022-06-20
Valid Till : 2025-08-08
Written Confirmation Number : WC-0113
Address of the Firm :
NDC Package Code : 53104-7609
Start Marketing Date : 2018-09-27
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
Registrant Name : LG Chemical Co., Ltd.
Registration Date : 2012-10-11
Registration Number : 20111118-177-I-11-10(1)
Manufacturer Name : Cipla Limited
Manufacturer Address : Virgonagar Post, Old Madras Road, Bangalore-560 049, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16470
Submission : 2003-03-10
Status : Inactive
Type : II
Date of Issue : 2020-11-27
Valid Till : 2021-06-07
Written Confirmation Number : WC-0317A2
Address of the Firm :
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?